A slimmer ReNeuron focuses on neural stem cells

Tuesday 30 June 2009

ReNeuron Group Plc, which cut its total expenses by about a third in the most recent financial year, has pinned its future on making the company’s neural stem cell therapy for stroke a success.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

See map: Google Maps